ESMO 2016: Single-arm trials for early access to cancer drugs
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer…